Literature DB >> 25894182

Synthetic graft for reconstruction of middle hepatic vein tributaries in living-donor liver transplant.

Refaat Kamel1, Yasser Hatata, Karim Hosny, Khaled Amer, Mohamed Taha.   

Abstract

OBJECTIVES: In middle hepatic vein dominant livers, the anterior segment of the right lobe of the liver (segments V and VIII) drains mainly into the middle hepatic vein. In these donors, when right lobe grafts are procured without the middle hepatic vein, the graft may harbor large segment V and/or VIII veins that need reconstruction to avoid graft congestion and subsequent graft dysfunction. Draining these middle hepatic vein tributaries using autologous or cryopreserved vessels is a solution, despite the possible difficulties of their preparation. However, these vessels are not always available. Our objective was to evaluate the effectiveness and safety of using a synthetic vascular graft.
MATERIALS AND METHODS: Between January 2012 and October 2013, eighteen adult recipients underwent living-donor liver transplant using right lobe grafts without the middle hepatic vein at Dar Al Fouad Hospital, 6th of October City, Egypt. All grafts had a large tributary of the middle hepatic vein. Eight-mm ringed expanded polytetrafluoroethylene vascular grafts were used to drain 15 segment V vein tributaries and 3 segment VIII vein tributaries directly to the inferior vena cava. Follow-up was done using duplex ultrasound to evaluate the patency of the vascular graft and the liver congestion and the liver function tests including liver enzymes.
RESULTS: Intraoperative Duplex ultrasound confirmed patency and absent segmental congestion in all 18 recipients. The vascular graft patency was 17/18 at 1 week (94.4%) and 15/18 at 1 month (83.3%). No recipients developed graft infection at 1 month.
CONCLUSIONS: Synthetic vascular expanded polytetrafluoroethylene grafts could be used effectively and safely in middle hepatic vein tributary reconstruction to overcome the unavailability of autologous or cryopreserved vessel grafts or just to avoid the additional burden of recovering autologous grafts thus simplifying the procedure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894182     DOI: 10.6002/ect.mesot2014.p159

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  2 in total

Review 1.  Living donor liver transplantation in Egypt.

Authors:  Khaled E Amer; Ibrahim Marwan
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

2.  Successful use of venous graft from native liver with hepatocellular carcinoma during living donor liver transplantation with no impact on recurrence rate: A retrospective cohort study.

Authors:  Hazem Mohamed Zakaria; Emad Hamdy Gad; Nahal Kamel Gaballa; Ahmed Nabil Sallam; Islam Ismail Ayoub; Mohamed Eltabbakh; Shimaa Saad Elkholy; Sameh Abokoura; Taha Yassein; Osama Hegazy; Hany Abdelmeguid Shoreem; Hossam Eldeen Mohamed Soliman; Amr Ahmed Aziz; Mohammad Taha
Journal:  Ann Med Surg (Lond)       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.